Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03539822
Title Cabozantinib in Combination With Durvalumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies (CAMILLA)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Anwaar Saeed

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

hepatocellular carcinoma

colorectal adenocarcinoma


Cabozantinib + Durvalumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.